About the Cancer Session
A set of illnesses known as cancer include abnormal cell proliferation and have the ability to infiltrate or spread to different bodily regions. These stand in contrast to benign tumours, which remain stationary. A lump, unusual bleeding, a persistent cough, unexplained weight loss, and a change in bowel habits are all potential warning signs and symptoms. These signs of cancer may be present, but there may be other reasons as well. Humans are susceptible to over 100 different malignancies. About 22% of cancer fatalities are related to tobacco usage. Another 10% of cases are brought on by obesity, a bad diet, a lack of exercise, or excessive alcohol consumption. Other concerns include exposure to ionising radiation, certain diseases, and environmental contaminants. Infections including Helicobacter pylori, hepatitis B, hepatitis C, human papillomavirus infection, Epstein-Barr virus, and human immunodeficiency virus account for 15% of cancer cases in underdeveloped countries (HIV). These elements influence a cell's genes, at least in part. Before cancer manifests, several genetic alterations are often necessary. 5–10%–of malignancies are brought on by inherited genetic flaws. A few warning signs and symptoms as well as screening tests can help diagnose cancer. Medical imaging is typically used to conduct additional research, followed by biopsy for confirmation.
Topics Covered in Cancer
Tumour biology and carcinogenesis
Cancer screening and early detection
Infection-related and viral cancers
Tobacco, alcohol and lifestyle risk factors
Hereditary cancer syndromes and genetic testing
Diagnostic imaging, biopsy and staging
Featured Speakers — Cancer 2027
Recent Research Presented at Cancer Sessions
Theory and perspective: Harnessing big data and artificial intelligence to uncover a universal principle for cancer elimination
Although numerous cancer-associated mechanisms are reported each year, a unifying theoretical framework capable of explaining—and ultimately enabling the elimination of—all cancers remains elusive…
Related Scientific Sessions at IPHC 2027
Why Attend the Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer work, reviewed by the scientific committee.
Network Globally
Meet public health researchers, educators, and policy leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IPHC 2027 for the Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Conference 2027 — FAQs
What is the Cancer track at IPHC 2027?
The Cancer track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer sessions?
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Cancer are all welcome — whether presenting or attending.
Can I present my research in the Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer sessions?
Yes. IPHC 2027 is a hybrid conference — attend the Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the IPHC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
